The condition may need a different approach, the dose may need adjustment, or the product quality may be questionable
Save 25% sitewide with my special code, BGFDAY25, for a limited time only
Certificate of Analysis (COA) [Instant Verification via QR Code]
They have no major side effects
What this means for you right now: BPC-157 and TB-500 are currently available through licensed compounding pharmacies under clinician supervision Thymosin Alpha-1 has a longer regulatory history and a more established compounding track record Sourcing from unregulated vendors carries real safety risks contamination, misdosing, and no quality control We've covered the full regulatory picture in detail here: PCAC Peptide Review 2026: What the July Advisory Panel Decision Means for BPC-157, TB-500, and Thymosin Alpha-1 What a Clinician-Supervised Long COVID Peptide Protocol Looks Like A responsible protocol starts with assessment not assumption
The cells were treated with MTT (5 mg/mL) for 4 hours at 37C
